Projects
decoration

Utility of a neurobehavioural assessment for treatment planning, educational, and family support for children undergoing bone marrow transplant for non-malignant disease. 

2023-2025 (Fiona Riewoldt Nursing/Allied Health Fellowship): Utility of a neurobehavioural assessment for treatment planning, educational, and family support for children undergoing bone marrow transplant for non-malignant disease. Alice Maier, The Royal Children’s Hospital.

Bone marrow transplantation is increasingly being offered as a cure for children with bone marrow failure syndromes and other non-malignant conditions. A bone marrow transplant is an intensive treatment with associated risks for child development that may be related to the therapy or the underlying disease. 

While there is substantial research on the risk factors that relate to poor long-term developmental, educational, and psychological outcomes in children with malignant conditions, little is known about the risks for children with non-malignant conditions like Bone Marrow Failure Syndromes. 

This study will implement a neurobehavioral assessment protocol (including evaluation of thinking skills, behaviour, emotional wellbeing, academic skills, and family functioning) as part of a routine pre-transplantation evaluation, and a review 100-days post-transplant, of children and their families undergoing a transplant at The Royal Children’s Hospital Melbourne. 

The assessment will provide the treating team with a comprehensive understanding of the individual needs of the patient and family to help guide treatment planning, promote proactive referral to support services, and identify educational requirements that can be addressed during and post-transplant. 

An overarching aim of the current study is to develop consensus guidelines for assessment and management of children’s neurobehavioral and educational needs before, during and post-transplant for patients with non-malignant conditions.

Related Projects

Modelling consequences of cell abundance, heterogeneity and origin for autologous cell therapy in genetic Bone Marrow Failure Syndromes.

2020-2023 (Fellowship): Modelling consequences of cell abundance, heterogeneity and origin for autologous cell therapy in genetic Bone Marrow Failure Syndromes. Dr Parvathy Venugopal, Centre for Cancer Biology / University of South Australia. In ...

Read more

Novel blood biomarkers for predicting bone marrow failure in Myeloproliferative neoplasms. 

2019-2023 (co-funded Snowdome/Gunn Family/Maddie Riewoldt’s Vision) The Gunn Family National Fellowship for Career Development in Research – Women in Haematology. Novel blood biomarkers for predicting bone marrow failure in Myeloproliferative ...

Read more

Dissecting immune dysregulation in acquired bone marrow failure syndromes to identify new therapeutic leads. 

2022-2025 (Fellowship): Dissecting immune dysregulation in acquired Bone Marrow Failure Syndromes to identify new therapeutic leads. Associate Professor Rachel Koldej, ACRF Translational Research Laboratory, Melbourne Health. Bone Marrow Failure ...

Read more

Discovery of novel niche factors to improve long-term stem cell transplantation in Bone Marrow Failure Syndromes. 

2023- 2025 (Fellowship): Discovery of novel niche factors to improve long-term stem cell transplantation in bone marrow failure syndromes. Dr Vashe Chandrakanthan, The University of Adelaide. For many patients with Bone Marrow Failure Syndromes, ...

Read more

Sign up to be the first to hear about our upcoming News & Events